Scarica l'app Stockscreener
3.86
4.46%
-0.18
Dopo l'orario di chiusura:
3.76
-0.10
-2.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
Is SELLAS Life Sciences Group Inc. stock a top pick in earnings seasonJuly 2025 Catalysts & Expert-Curated Trade Recommendations - ulpravda.ru
Published on: 2026-01-09 05:48:17 - ulpravda.ru
Why SELLAS Life Sciences Group Inc. stock could outperform in 2025July 2025 Breakouts & AI Powered Buy/Sell Recommendations - ulpravda.ru
Why global investors buy SELLAS Life Sciences Group Inc. (RXK3) stock2025 Valuation Update & Scalable Portfolio Growth Ideas - ulpravda.ru
Published on: 2026-01-08 22:04:52 - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
Dip Buying: How interest rate cuts could boost SELLAS Life Sciences Group Inc. stockJuly 2025 Earnings & AI Optimized Trading Strategy Guides - ulpravda.ru
Best Penny Stocks To Follow TodayJanuary 4th - MarketBeat
SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B - Asianet Newsable
Penny Stocks To Follow TodayJanuary 3rd - MarketBeat
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
A Look At SELLAS Life Sciences Group (SLS) Valuation As REGAL Phase 3 Trial Nears Final Event Trigger - simplywall.st
SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS TriggerHas The Bull Case Changed? - Yahoo Finance
SELLAS Life Sciences (ASX:SLS) Shares Flat After Phase 3 Update - Kalkine Media
Is the Event-Driven REGAL Trial Timeline Reframing SELLAS Life Sciences Group’s (SLS) Risk-Reward Profile? - simplywall.st
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
SELLAS Life Sciences Stock Surges as Phase 3 Trial Nears Data Trigger - StocksToTrade
Why Is SLS Stock Drawing Significant Investor Attention Today? - Asianet Newsable
Ironwood Pharmaceuticals, Baidu, Vertiv Holdings And Other Big Stocks Moving Higher On Friday - Benzinga
SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 Trial Progress - Quiver Quantitative
SELLAS Life Sciences Group stock soars as it nears final analysis in cancer study - MSN
Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? - RTTNews
SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus - ts2.tech
Sellas Life Sciences Showcases Promising Phase 2 Data at Annual Meeting - StocksToTrade
Sellas Life Sciences Showcases Breakthroughs in AML Treatment - timothysykes.com
Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday - Benzinga
Largest borrow rate increases among liquid names - TipRanks
SELLAS Life Sciences Stock Surge: Buy or Wait? - StocksToTrade
SELLAS’s Therapy Triumph: Market Buzz - timothysykes.com
Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S in Acute Myeloid Leukemia - MarketScreener
SELLAS Reports Continued Progress In Phase 3 REGAL Trial Of GPS In Acute Myeloid Leukemia - Nasdaq
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next - ts2.tech
Sellas Life Sciences Stock Surges After Positive Clinical Trials - StocksToTrade
SELLAS Life Sciences Stock Is Surging Higher: What's Going On? - Benzinga
Sellas Life Sciences stock soars after trial update shows slower event rate - Investing.com Nigeria
Sellas Life Sciences stock soars after trial update shows slower event rate By Investing.com - Investing.com South Africa
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):